{"transactions":[{"id":737389,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-15T21:57:01.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date."}],"balance_after":2700,"derivative":{"exercise_price":0.947,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000912282-26-000832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000091228226000832/form4.xml","form_type":"4"}},{"id":934012,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-01-21T23:05:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":29423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2026 provided for under the Issuer's Outside Director Compensation Policy."}],"balance_after":29423,"derivative":{"exercise_price":3,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":29423},"source":{"system":"sec-edgar","filing":"0000912282-26-000085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000091228226000085/form4.xml","form_type":"4"}},{"id":1119127,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-06T21:33:18.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 100% on the one-year anniversary of the grant date.  The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the issuer's Outside Director Compensation Policy."}],"balance_after":27000,"derivative":{"exercise_price":1.09,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000912282-25-000619","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000091228225000619/form4.xml","form_type":"4"}},{"id":1306349,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-01-09T00:30:58.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":47587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy."}],"balance_after":47587,"derivative":{"exercise_price":1.88,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":47587},"source":{"system":"sec-edgar","filing":"0001415889-25-001162","document":"form4-01092025_120154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000141588925001162/form4-01092025_120154.xml","form_type":"4"}},{"id":1486075,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-08T01:08:59.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date."}],"balance_after":27000,"derivative":{"exercise_price":0.82,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001415889-24-016093","document":"form4-06082024_010656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000141588924016093/form4-06082024_010656.xml","form_type":"4"}},{"id":1710594,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T23:21:33.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":22627,"price":1.04,"value":23532.08,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $1.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2347545,"source":{"system":"sec-edgar","filing":"0001209191-23-058694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123058694/doc4.xml","form_type":"4"}},{"id":1710593,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T23:21:33.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":22627,"price":1,"value":22627.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2324918,"source":{"system":"sec-edgar","filing":"0001209191-23-058694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123058694/doc4.xml","form_type":"4"}},{"id":1710592,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T23:21:33.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":22327,"price":1.02,"value":22773.54,"ownership":{"direct":true},"balance_after":2302291,"source":{"system":"sec-edgar","filing":"0001209191-23-058694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123058694/doc4.xml","form_type":"4"}},{"id":1710591,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T23:21:33.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":1,"value":300.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2279964,"source":{"system":"sec-edgar","filing":"0001209191-23-058694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123058694/doc4.xml","form_type":"4"}},{"id":1718834,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-07T23:30:10.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":19123,"price":1.01,"value":19314.23,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2279664,"source":{"system":"sec-edgar","filing":"0001209191-23-057799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057799/doc4.xml","form_type":"4"}},{"id":1718833,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-07T23:30:10.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":19123,"price":1.02,"value":19505.46,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2260541,"source":{"system":"sec-edgar","filing":"0001209191-23-057799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057799/doc4.xml","form_type":"4"}},{"id":1718832,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-07T23:30:10.000Z","date":"2023-12-05","kind":"purchase","planned":false,"acquired":true,"shares":19123,"price":1.01,"value":19314.23,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2241418,"source":{"system":"sec-edgar","filing":"0001209191-23-057799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057799/doc4.xml","form_type":"4"}},{"id":1725047,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T18:38:01.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":14378,"price":0.94,"value":13515.32,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.91 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2222295,"source":{"system":"sec-edgar","filing":"0001209191-23-057053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057053/doc4.xml","form_type":"4"}},{"id":1725046,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T18:38:01.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":14378,"price":0.9,"value":12940.2,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2207917,"source":{"system":"sec-edgar","filing":"0001209191-23-057053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057053/doc4.xml","form_type":"4"}},{"id":1725045,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T18:38:01.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":14378,"price":0.98,"value":14090.44,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2193539,"source":{"system":"sec-edgar","filing":"0001209191-23-057053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123057053/doc4.xml","form_type":"4"}},{"id":1791692,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-31T22:42:15.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":41026,"price":1.32,"value":54154.32,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2179161,"source":{"system":"sec-edgar","filing":"0001209191-23-047880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123047880/doc4.xml","form_type":"4"}},{"id":1791691,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-31T22:42:15.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":41026,"price":1.31,"value":53744.06,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2138135,"source":{"system":"sec-edgar","filing":"0001209191-23-047880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123047880/doc4.xml","form_type":"4"}},{"id":1802865,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T22:08:21.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":24766,"price":1.29,"value":31948.14,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2097109,"source":{"system":"sec-edgar","filing":"0001209191-23-046402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123046402/doc4.xml","form_type":"4"}},{"id":1802864,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T22:08:21.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":117348,"price":1.29,"value":151378.92,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":2072343,"source":{"system":"sec-edgar","filing":"0001209191-23-046402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123046402/doc4.xml","form_type":"4"}},{"id":1802863,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T22:08:21.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":107886,"price":1.32,"value":142409.52,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.34, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1954995,"source":{"system":"sec-edgar","filing":"0001209191-23-046402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123046402/doc4.xml","form_type":"4"}},{"id":1875869,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-26T21:47:13.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of May 24, 2023."}],"balance_after":27000,"derivative":{"exercise_price":1.58,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-032674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123032674/doc4.xml","form_type":"4"}},{"id":2237238,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T00:43:36.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the stock option shall vest in full on the one-year anniversary of the grant date of June 8, 2022."}],"balance_after":27000,"derivative":{"exercise_price":3.23,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-22-035672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919122035672/doc4.xml","form_type":"4"}},{"id":2243656,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T16:38:33.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":59459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting."}],"balance_after":59459,"derivative":{"exercise_price":1.85,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":59459},"source":{"system":"sec-edgar","filing":"0001209191-22-034086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652724/000120919122034086/doc4.xml","form_type":"4"}},{"id":2255398,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T17:17:40.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on May 24, 2022 will become vested on the earlier of (i) May 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":3.13,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-032263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122032263/doc4.xml","form_type":"4"}},{"id":2259363,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-24T00:09:08.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":200002,"ownership":{"direct":false,"nature":"By David A. Lamond Trust dated 2006"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2022, the Issuer completed acquisition (the \"Merger\") of Novosteo Inc. (\"Novosteo\"), pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, (the \"Merger Agreement\"), by and among the Issuer, Quince Merger Sub I, Inc., a wholly owned subsidiary of the Issuer, Quince Merger Sub II, LLC, a wholly owned subsidiary of the Issuer, Novosteo, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative. Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by the Reporting Person in Novosteo were automatically cancelled and converted into the right to receive shares of common stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the \"2006 Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust."}],"balance_after":1734722,"source":{"system":"sec-edgar","filing":"0001209191-22-031500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919122031500/doc4.xml","form_type":"4"}},{"id":2260192,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T18:18:19.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":33500,"price":3.26,"value":109210.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.32, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Blue Devil Trust for which the Reporting Person serves as trustee."}],"balance_after":1077519,"source":{"system":"sec-edgar","filing":"0001209191-22-031435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122031435/doc4.xml","form_type":"4"}},{"id":2260191,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T18:18:19.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":33000,"price":3.08,"value":101640.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.03 to $3.14, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Blue Devil Trust for which the Reporting Person serves as trustee."}],"balance_after":1044019,"source":{"system":"sec-edgar","filing":"0001209191-22-031435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122031435/doc4.xml","form_type":"4"}},{"id":2662765,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:25:11.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":11029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the stock option shall vest in full on the one-year anniversary of the grant date of June 16, 2021."}],"balance_after":11029,"derivative":{"exercise_price":50.56,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":11029},"source":{"system":"sec-edgar","filing":"0001209191-21-041711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121041711/doc4.xml","form_type":"4"}},{"id":2703431,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T19:05:22.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":15175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on May 18, 2021 will become vested on the earlier of (i) May 18, 2022 or (ii) the business day prior to the date of the 2022 annual meeting of stockholders."}],"balance_after":15175,"derivative":{"exercise_price":47.01,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":15175},"source":{"system":"sec-edgar","filing":"0001209191-21-034608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121034608/doc4.xml","form_type":"4"}},{"id":2754469,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T18:47:11.000Z","date":"2021-04-06","kind":"purchase","acquired":true,"shares":25000,"price":42,"value":1050000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held directly by the Blue Devil Trust for which the Reporting Person serves as trustee, and holds voting and dispositive power."}],"balance_after":1011019,"source":{"system":"sec-edgar","filing":"0001209191-21-025973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121025973/doc4.xml","form_type":"4"}},{"id":2772760,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T01:06:12.000Z","date":"2021-03-24","kind":"purchase","acquired":true,"shares":50000,"price":33.77,"value":1688500.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.51\nto $33.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the\nshares held of record by the Trust."}],"balance_after":1847109,"source":{"system":"sec-edgar","filing":"0001209191-21-022947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121022947/doc4.xml","form_type":"4"}},{"id":2774112,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T23:13:06.000Z","date":"2021-03-04","kind":"gift","acquired":true,"shares":1534720,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By David A. Lamond Trust dated 2006"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 4, 2021, in accordance with the provisions of a Grantor Retained Annuity Trust (the \"GRAT\"), 1,534,720 shares were distributed from the GRAT to the David A. Lamond Trust dated 2006 for the benefit of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the \"2006 Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust."}],"balance_after":1534720,"source":{"system":"sec-edgar","filing":"0001209191-21-022688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121022688/doc4.xml","form_type":"4"}},{"id":2805163,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-05T22:54:39.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":4100,"price":36.86,"value":151126.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $36.76 to $36.96, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1797109,"source":{"system":"sec-edgar","filing":"0001209191-21-018328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121018328/doc4.xml","form_type":"4"}},{"id":2805162,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-05T22:54:39.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":15969,"price":36.34,"value":580313.46,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $35.75 to $36.73, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1793009,"source":{"system":"sec-edgar","filing":"0001209191-21-018328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121018328/doc4.xml","form_type":"4"}},{"id":2805161,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-05T22:54:39.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":13310,"price":35,"value":465850.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $34.75 to $35.70, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1777040,"source":{"system":"sec-edgar","filing":"0001209191-21-018328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121018328/doc4.xml","form_type":"4"}},{"id":2805160,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-05T22:54:39.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":16621,"price":34.28,"value":569767.88,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $33.75 to $34.70, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1763730,"source":{"system":"sec-edgar","filing":"0001209191-21-018328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121018328/doc4.xml","form_type":"4"}},{"id":2871160,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-02-09T19:50:26.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":92756,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Blue Devil Trust, for which Mr. Lamond serves as a trustee."}],"balance_after":0,"derivative":{"underlying":"02/09/2021","underlying_shares":92756},"source":{"system":"sec-edgar","filing":"0001209191-21-009039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652724/000120919121009039/doc4.xml","form_type":"4"}},{"id":2871159,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-02-09T19:50:26.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":53629,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Blue Devil Trust, for which Mr. Lamond serves as a trustee."}],"balance_after":0,"derivative":{"underlying":"02/09/2021","underlying_shares":53629},"source":{"system":"sec-edgar","filing":"0001209191-21-009039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1652724/000120919121009039/doc4.xml","form_type":"4"}},{"id":2871158,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:50:26.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":92756,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Blue Devil Trust, for which Mr. Lamond serves as a trustee."}],"balance_after":146385,"source":{"system":"sec-edgar","filing":"0001209191-21-009039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652724/000120919121009039/doc4.xml","form_type":"4"}},{"id":2871157,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:50:26.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":53629,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Blue Devil Trust, for which Mr. Lamond serves as a trustee."}],"balance_after":53629,"source":{"system":"sec-edgar","filing":"0001209191-21-009039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652724/000120919121009039/doc4.xml","form_type":"4"}},{"id":3113592,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-06-11T18:38:29.000Z","date":"2020-06-09","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by the Blue Devil Trust for which Mr. Lamond serves as trustee and over which shares Mr. Lamond holds voting and dispositive power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001209191-20-036057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919120036057/doc4.xml","form_type":"4"}},{"id":3113591,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-06-11T18:38:29.000Z","date":"2020-06-09","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by the Blue Devil Trust for which Mr. Lamond serves as trustee and over which shares Mr. Lamond holds voting and dispositive power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001209191-20-036057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919120036057/doc4.xml","form_type":"4"}},{"id":3113590,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-11T18:38:29.000Z","date":"2020-06-09","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by the Blue Devil Trust for which Mr. Lamond serves as trustee and over which shares Mr. Lamond holds voting and dispositive power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001209191-20-036057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919120036057/doc4.xml","form_type":"4"}},{"id":3113589,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T18:38:29.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":71430,"price":14,"value":1000020.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by the Blue Devil Trust for which Mr. Lamond serves as trustee and over which shares Mr. Lamond holds voting and dispositive power."}],"balance_after":986019,"source":{"system":"sec-edgar","filing":"0001209191-20-036057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919120036057/doc4.xml","form_type":"4"}},{"id":3113588,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T18:38:29.000Z","date":"2020-06-09","kind":"exercise","acquired":true,"shares":914589,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of issuer's common stock immediately prior to the closing of the issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by the Blue Devil Trust for which Mr. Lamond serves as trustee and over which shares Mr. Lamond holds voting and dispositive power."}],"balance_after":914589,"source":{"system":"sec-edgar","filing":"0001209191-20-036057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919120036057/doc4.xml","form_type":"4"}},{"id":3115778,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T00:12:53.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":11029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall fully vest on the one-year anniversary of the grant date, subject to the reporting person's continued services as a member of the board of directors of Cortexyme, Inc. through such vesting date."}],"balance_after":11029,"derivative":{"exercise_price":41.73,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":11029},"source":{"system":"sec-edgar","filing":"0001209191-20-035419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120035419/doc4.xml","form_type":"4"}},{"id":3118077,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T22:47:15.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":24874,"price":43.8765,"value":1091384.061,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the shares of Common Stock is from $43.61 to $44.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1747109,"source":{"system":"sec-edgar","filing":"0001209191-20-035104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/doc4.xml","form_type":"4"}},{"id":3118076,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T22:47:15.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":10642,"price":43.3221,"value":461033.7882,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of prices for the shares of Common Stock is from $42.61 to $43.60. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1722235,"source":{"system":"sec-edgar","filing":"0001209191-20-035104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/doc4.xml","form_type":"4"}},{"id":3118075,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T22:47:15.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":13609,"price":42.1322,"value":573377.1098,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $41.58 to $42.55. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1711593,"source":{"system":"sec-edgar","filing":"0001209191-20-035104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/doc4.xml","form_type":"4"}},{"id":3142047,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":32894,"price":56.4157,"value":1855738.0358,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The range of prices for the shares of Common Stock is from $55.90\nto $56.87. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1697984,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142046,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":5906,"price":55.4197,"value":327308.7482,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The range of prices for the shares of Common Stock is from $54.895 to $55.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1665090,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142045,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":400,"price":54.09,"value":21636.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The range of prices for the shares of Common Stock is from $53.65\nto $54.53. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1659184,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142044,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":100,"price":53.1,"value":5310.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1658784,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142043,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":500,"price":52.201,"value":26100.5,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The range of prices for the shares of Common Stock is from $51.95\nto $52.57. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1658684,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142042,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":1000,"price":50.7073,"value":50707.3,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The range of prices for the shares of Common Stock is from $50.38\nto $51.36. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1658184,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142041,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":1600,"price":48.9584,"value":78333.44,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the shares of Common Stock is from $48.70\nto $49.625. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1657184,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142040,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":985,"price":48.365,"value":47639.525,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of prices for the shares of Common Stock is from $47.68 to $48.64. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1655584,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3142039,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T22:41:45.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":1263,"price":46.3007,"value":58477.7841,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $45.80\nto $46.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1654599,"source":{"system":"sec-edgar","filing":"0001209191-20-030688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/doc4.xml","form_type":"4"}},{"id":3281523,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:18:36.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":30000,"price":50,"value":1500000.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the \"Trust\") and holds sole voting and dispositive power with respect to the shares held of record by the Trust."}],"balance_after":1653336,"source":{"system":"sec-edgar","filing":"0001209191-20-008073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120008073/doc4.xml","form_type":"4"}},{"id":3529084,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2019-05-13T23:48:34.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":924056,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lamond is the trustee of the Blue Devil Trust dated 12/03/2010, and holds sole voting and dispositive power with respect to the shares held of record by Blue Devil Trust dated 12/03/2010."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":924056},"source":{"system":"sec-edgar","filing":"0001209191-19-029476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/doc4.xml","form_type":"4"}},{"id":3529083,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2019-05-13T23:48:34.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":301829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":301829},"source":{"system":"sec-edgar","filing":"0001209191-19-029476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/doc4.xml","form_type":"4"}},{"id":3529082,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2019-05-13T23:48:34.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":699280,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lamond is the trustee of the Blue Devil Trust dated 12/03/2010, and holds sole voting and dispositive power with respect to the shares held of record by Blue Devil Trust dated 12/03/2010."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":699280},"source":{"system":"sec-edgar","filing":"0001209191-19-029476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/doc4.xml","form_type":"4"}},{"id":3529081,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T23:48:34.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":301829,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."}],"balance_after":301829,"source":{"system":"sec-edgar","filing":"0001209191-19-029476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/doc4.xml","form_type":"4"}},{"id":3529080,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":38020,"kind":"person","name":"Lamond David","position":1,"cik":"0001770790","reported_name":"Lamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T23:48:34.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":1623336,"ownership":{"direct":false,"nature":"By Blue Devil Trust dated 12/03/2010"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lamond is the trustee of the Blue Devil Trust dated 12/03/2010, and holds sole voting and dispositive power with respect to the shares held of record by Blue Devil Trust dated 12/03/2010."}],"balance_after":1623336,"source":{"system":"sec-edgar","filing":"0001209191-19-029476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/doc4.xml","form_type":"4"}}]}